(Q35845925)

10 August 2017

title

Protein particle vaccines against malaria (English)

1 reference

10 August 2017

1 reference

1 reference

1

1 reference

10 August 2017

Hill AV

2

1 reference

10 August 2017

publication date

1 August 1997

1 reference

10 August 2017

published in

Trends in Parasitology

1 reference

10 August 2017

volume

13

1 reference

10 August 2017

issue

8

1 reference

10 August 2017

page(s)

302-306

1 reference

Circumventing genetic restriction of protection against malaria with multigene DNA immunization: CD8+ cell-, interferon gamma-, and nitric oxide-dependent immunity

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Do DNA vaccines induce autoimmune disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Chimeric hepatitis B core antigen particles containing B- and Th-epitopes of human papillomavirus type 16 E7 protein induce specific antibody and T-helper responses in immunised mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Priming of class I-restricted cytotoxic T lymphocytes by vaccination with recombinant protein antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Epitopes of the human malaria parasite P. falciparum carried on the surface of HBsAg particles elicit an immune response against the parasite

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Phase I Clinical Trial of a Recombinant Malaria Vaccine Consisting of the Circumsporozoite Repeat Region of Plasmodium Falciparum Coupled to Hepatitis B Surface Antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Safety, immunogenicity, and efficacy of a recombinantly produced Plasmodium falciparum circumsporozoite protein-hepatitis B surface antigen subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

A preliminary evaluation of a recombinant circumsporozoite protein vaccine against Plasmodium falciparum malaria. RTS,S Malaria Vaccine Evaluation Group

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

T cell responses to repeat and non-repeat regions of the circumsporozoite protein detected in volunteers immunized with Plasmodium falciparum sporozoites

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Identification of conserved antigenic components for a cytotoxic T lymphocyte-inducing vaccine against malaria

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Hybrid hepatitis B virus core antigen as a vaccine carrier moiety: I. presentation of foreign epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Immunity to malaria elicited by hybrid hepatitis B virus core particles carrying circumsporozoite protein epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

The expression of hybrid HIV:Ty virus-like particles in yeast

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Comparison of numerous delivery systems for the induction of cytotoxic T lymphocytes by immunization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

An HLA-based approach to the design of a CTL-inducing vaccine against Plasmodium falciparum

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Immunogenicity of the yeast recombinant p17/p24:Ty virus-like particles (p24-VLP) in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

The effects of adjuvants on CTL induction by V3:Ty-virus-like particles (V3-VLPs) in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Systemic production of foreign peptides on the particle surface of tobacco mosaic virus

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Induction of HIV type 1 neutralizing and env-CD4 blocking antibodies by immunization with genetically engineered HIV type 1-like particles containing unprocessed gp160 glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

In vivo induction of CD4+ T cell responses by antigens covalently linked to synthetic microspheres does not require adjuvant.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Synthetic delivery system for tuberculosis vaccines: immunological evaluation of the M. tuberculosis 38 kDa protein entrapped in biodegradable PLG microparticles

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Mapping of two overlapping linear epitopes in Pfg27 recognized by Plasmodium falciparum transmission-blocking monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1016%2FS0169-4758%2897%2901091-0

7 January 2021

10.1016/S0169-4758(97)01091-0

Identifiers

DOI

1 reference

10 August 2017

1 reference